Edaravone - CAS 89-25-8
Catalog number: 89-25-8
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C10H10N2O
Molecular Weight:
174.2
COA:
Inquire
Targets:
Others
Description:
Edaravone is a novel potent free radical scavenger that reduces reactive oxygen species, inhibites apoptosis, and blocks nonenzymatic peroxidation and lipoxygenase activity.
Purity:
>98%
Synonyms:
Edaravone; MCI-186; MCI 186; MCI186; Radicut; Arone
MSDS:
Inquire
InChIKey:
QELUYTUMUWHWMC-UHFFFAOYSA-N
InChI:
InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3
Canonical SMILES:
CC1=NN(C(=O)C1)C2=CC=CC=C2
1.Edaravone suppresses degradation of type II collagen.
Huang C1, Liao G2, Han J2, Zhang G2, Zou B2. Biochem Biophys Res Commun. 2016 Mar 30. pii: S0006-291X(16)30448-X. doi: 10.1016/j.bbrc.2016.03.136. [Epub ahead of print]
Osteoarthritis (OA) is a degenerative joint disease affecting millions of people. The degradation and loss of type II collagen induced by proinflammatory cytokines secreted by chondrocytes, such as factor-α (TNF-α) is an important pathological mechanism to the progression of OA. Edaravone is a potent free radical scavenger, which has been clinically used to treat the neuronal damage following acute ischemic stroke. However, whether Edaravone has a protective effect in articular cartilage hasn't been reported before. In this study, we investigated the chondrocyte protective effects of Edaravone on TNF-α induced degradation of type Ⅱ collagen. And our results indicated that TNF-α treatment resulted in degradation of type Ⅱ collagen, which can be ameliorated by treatment with Edaravone in a dose dependent manner. Notably, it was found that the inhibitory effects of Edaravone on TNF-α-induced reduction of type Ⅱ collagen were mediated by MMP-3 and MMP-13.
2.Protective Effects of Edaravone in Adult Rats with Surgery and Lipopolysaccharide Administration-Induced Cognitive Function Impairment.
Wang P1, Cao J1, Liu N1,2, Ma L1,3, Zhou X1, Zhang H1, Wang Y4. PLoS One. 2016 Apr 26;11(4):e0153708. doi: 10.1371/journal.pone.0153708. eCollection 2016.
Postoperative cognitive dysfunction (POCD) is a clinical syndrome characterized by cognitive declines in patients after surgery. Previous studies have suggested that surgery contributed to such impairment. It has been proven that neuroinflammation may exacerbate surgery-induced cognitive impairment in aged rats. The free radical scavenger edaravone has high blood brain barrier permeability, and was demonstrated to effectively remove free radicals from the brain and alleviate the development of POCD in patients undergoing carotid endarterectomy, suggesting its potential role in preventing POCD. For this reason, this study was designed to determine whether edaravone is protective against POCD through its inhibitory effects on inflammatory cytokines and oxidative stress. First, Sprague Dawley adult male rats were administered 3 mg/kg edaravone intraperitoneally after undergoing a unilateral nephrectomy combined with lipopolysaccharide injection.
3.Could edaravone prevent gentamicin ototoxicity? An experimental study.
Turan M1, Ciğer E2, Arslanoğlu S2, Börekci H3, Önal K2. Hum Exp Toxicol. 2016 Mar 27. pii: 0960327116639360. [Epub ahead of print]
OBJECTIVES: Clinical application of gentamicin may cause nephrotoxicity and ototoxicity. Our study is the first study to investigate the protective effects of edaravone against the gentamicin-induced ototoxicity. We investigated the protective effect of intraperitoneal (i.p.) edaravone application against gentamicin-induced ototoxicity in guinea pigs.
4.Edaravone promotes activation of resident cardiac stem cells by transplanted mesenchymal stem cells in a rat myocardial infarction model.
Zhang GW1, Gu TX2, Sun XJ3, Wang C4, Qi X5, Wang XB6, Li-Ling J7. J Thorac Cardiovasc Surg. 2016 Mar 12. pii: S0022-5223(16)00430-X. doi: 10.1016/j.jtcvs.2016.02.071. [Epub ahead of print]
OBJECTIVE: To explore the effect of edaravone on bone marrow mesenchymal stem cells (BMSCs) transplanted to treat acute myocardial infarction (AMI) and the underlying mechanism.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 68506-86-5 Vigabatrin

Vigabatrin
(CAS: 68506-86-5)

Vigabatrin is a structural analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) that irreversibly inhibits the catabolism of GABA by GABA transa...

CAS 329216-63-9 Quetiapine metabolite Quetiapine sulfoxide

Quetiapine metabolite Quetiapine sulfoxi
(CAS: 329216-63-9)

Quetiapine metabolite Quetiapine sulfoxide, a metabolite of Quetiapine, has antipsychotic effect.

CAS 88903-69-9 (-)-Xestospongin C

(-)-Xestospongin C
(CAS: 88903-69-9)

(-)-Xestospongin C is a potent and reversible inhibitor of IP3 receptor that reguates calcium release. (-)-Xestospongin C has been found to inhibit bradykinin-i...

Pocapavir
(CAS: 146949-21-5)

Pocapavir has been found to be an antienterovirus agent that could probably be effctive against enterovirus infections. The Phase-II trial for Poliomyelitis has...

CAS 1646-88-4 Aldicarb sulfone

Aldicarb sulfone
(CAS: 1646-88-4)

Aldicarb Sulfone is an analog of Aldicarb detected in agricultural products as pesticide residue.

CAS 105558-26-7 Ginsenoside Rh3

Ginsenoside Rh3
(CAS: 105558-26-7)

Ginsenoside Rh3 is isolated from red ginseng and metabolized from ginsenoside Rg5 and could be used as an anti-inflammatory agent.

CAS 136719-25-0 NB-598 hydrochloride

NB-598 hydrochloride
(CAS: 136719-25-0)

NB-598 is a potent competitive inhibitor of squalene epoxidase (SE).

CAS 109552-15-0 Pamidronate disodium pentahydrate

Pamidronate disodium pentahydrate
(CAS: 109552-15-0)

Pamidronate disodium pentahydrate is a nitrogen-containing bisphosphonate, used to prevent osteoporosis.

Chemical Structure

CAS 89-25-8 Edaravone

Quick Inquiry

Verification code

Featured Items